Study to Investigate the Efficacy and Safety of Vardenafil Flexible Dose Versus Placebo in Males With Erectile Dysfunction
Public ClinicalTrials.gov record NCT00657033. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double Blind, Parallel Group, Multi-center Study to Investigate the Efficacy and Safety of Vardenafil Flexible Dose Versus Placebo in Males With Erectile Dysfunction, and Their Female Partners' Sexual Quality of Life.
Study identification
- NCT ID
- NCT00657033
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Bayer
- Industry
- Enrollment
- 229 participants
Conditions and interventions
Conditions
Interventions
- Levitra (Vardenafil, BAY38-9456) Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2003
- Primary completion
- Not listed
- Completion
- Jul 31, 2004
- Last update posted
- Oct 13, 2013
2003 – 2004
United States locations
- U.S. sites
- 18
- U.S. states
- 9
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Phoenix | Arizona | 85023 | — |
| Not listed | Beverly Hills | California | 90212 | — |
| Not listed | Irvine | California | 92618-3603 | — |
| Not listed | Newport Beach | California | 92660 | — |
| Not listed | San Bernardino | California | 92404 | — |
| Not listed | San Diego | California | 92101 | — |
| Not listed | San Diego | California | 92128 | — |
| Not listed | Trumbull | Connecticut | 06611 | — |
| Not listed | Jacksonville | Florida | 32257 | — |
| Not listed | Riverdale | Georgia | 30274 | — |
| Not listed | Greenbelt | Maryland | 20770 | — |
| Not listed | Lutherville | Maryland | 21093 | — |
| Not listed | Lawrenceville | New Jersey | 08648 | — |
| Not listed | New Brunswick | New Jersey | 08901 | — |
| Not listed | New York | New York | 10016 | — |
| Not listed | Charlotte | North Carolina | 28209 | — |
| Not listed | Statesville | North Carolina | 28677 | — |
| Not listed | Wilmington | North Carolina | 28412 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00657033, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 13, 2013 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00657033 live on ClinicalTrials.gov.